ClinicalTrials.gg
RecruitingNCT04411719Updated Aug 14, 2023

Outcome Prediction in Patients With Acute Disorders of Consciousness

An observational study in Consciousness Disorder, sponsored by First Affiliated Hospital of Zhejiang University. Recruiting at 1 site in China. Open to participants aged 18 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-08-14.

Sponsored by First Affiliated Hospital of Zhejiang University · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Jul 2024, 2 years 4 months ago, but the record still lists the study as recruiting.
  • Started Jan 2022; still recruiting 4 years 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
60
Ages
18 Years to 85 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 17 studies in Consciousness Disorders by First Affiliated Hospital of Zhejiang University — 4 open to participants now, 4 under way, none of them phase 3. Consciousness Disorders · First Affiliated Hospital of Zhejiang University.

Planned enrollment
8th of 10
60 · median 190
Started
2022
with 2 others
Observational
10 of 17
3 open now
Registered
9th of 17
by date

Among the 17 studies in Consciousness Disorders by First Affiliated Hospital of Zhejiang University, this one is the 8th largest by planned enrollment of the 10 observational ones that give a count, is one of 3 that started in 2022, is one of 10 observational ones, and was the 9th registered.

Consciousness Disorders

291 studies on the registry are indexed under Consciousness Disorders; 109 are open to participants now.

Browse Consciousness Disorders studies →

Open to participants now

4 of the 17 studies in Consciousness Disorders by First Affiliated Hospital of Zhejiang University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Where they have run

Who these studies take

Of the 74 Consciousness Disorders studies recruiting now, 31 (42%) set no upper age limit and 24 (32%) stop at 75 or younger; 12 take children under 18; 15 take healthy volunteers.

This study: 18 Years to 85 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 17 studies in Consciousness Disorders by First Affiliated Hospital of Zhejiang University, or all of them as a file.
02

Study summary

Prior research has indicated a link between outcomes in patients with disorders of consciousness (DOC) and their responses to emotional auditory stimuli. Given the high degree of uncertainty in acute situations, this study plans to record EEG responses and observe microexpressions in DOC patients during exposure to auditory stimuli, with the aim to identify more reliable prognostic indicators. The goal is to uncover potential patterns or signals that can contribute to a more comprehensive understanding of a patient's condition, and thereby provide more accurate prognostication.

Read the detailed description

This study intends to probe the potential of electroencephalography (EEG) and microexpression analysis for predicting the outcomes of acutely unresponsive patients within the intensive care unit (ICU). Previous research has illuminated a relationship between patients' emotional responses to auditory stimuli and their prognosis. However, the predictive utility of these responses in the context of acute conditions remains largely unexplored.

At the onset of the study, participants will undergo EEG monitoring while exposed to a pre-determined set of emotional auditory stimuli. Additionally, the patients' facial expressions will be captured via video for subsequent microexpression analysis.

Follow-up assessments of the patients' status will be conducted at three, six, and twelve-month intervals. Using cutting-edge analytical techniques, the goal is to decode these EEG and microexpression responses. This study aims to identify possible correlations between these findings, the patients' diagnoses, and their respective outcomes over time.

03

Conditions studied

  • Consciousness Disorder
04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Unresponsive patients after severe brain injury.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with acute brain injury (\<28 days) in ICU
  • GCS ≤ 8
  • ≥ 2 days after sedation
  • Normal hearing, with auditory startle reflex

Exclusion criteria

Exclusion Criteria:

  • Children under 18
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
60 participants (estimated)
Patient registry
No

Groups and cohorts

  • EEG and Microexpression Analysis

    Participants will be acutely unresponsive ICU patients. They will undergo non-invasive observational procedures, including EEG monitoring during exposure to emotional auditory stimuli, and concurrent video recording for microexpression analysis. Patient outcomes will be assessed at three, six, and twelve-month intervals post-initial observation.

06

What researchers measure

Primary outcomes

  1. Glasgow Outcome Scale-Extended (GOS-E)

    GOS-E is an extended version of the Glasgow Outcome Scale (GOS), which was developed to provide a more detailed assessment of patient functionality and quality of life after experiencing such an injury. It has eight categories: Dead, Vegetative State, Lower Severe Disability, Upper Severe Disability, Lower Moderate Disability, Upper Moderate Disability, Lower Good Recovery, and Upper Good Recovery.

    Time frame: Month 1

  2. Glasgow Outcome Scale-Extended (GOS-E)

    GOSE will be assessed 3 months after brain injury.

    Time frame: Month 3

  3. Glasgow Outcome Scale-Extended (GOS-E)

    GOSE will be assessed 6 months after brain injury.

    Time frame: Month 6

  4. Glasgow Outcome Scale-Extended (GOS-E)

    GOSE will be assessed 12 months after brain injury.

    Time frame: Month 12

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2022 (actual). Primary completion is estimated for Jul 2024, 30 months after the start.

Of 57 non-industry observational studies under Consciousness Disorders, half reached primary completion within 41 months of starting (the median), counting those still running; a quarter within 24 and three quarters within 95. This study's planned 30 months is below that.

Counting every sponsor, half of 59 studies reached it within 40 months; a quarter within 22 and three quarters within 95.

How these figures are worked out, and which studies are left out of them.

Registered
May 28, 2020
First posted
Jun 2, 2020
StartActual
Jan 1, 2022
Primary completionEst.
Jul 1, 2024
CompletionEst.
Dec 1, 2024
Last update
Aug 14, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 14, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04411719
Responsible party
Sponsor
First posted
Jun 2, 2020
Start date
Jan 1, 2022
Primary completion
Jul 1, 2024 (estimated)
Completion
Dec 1, 2024 (estimated)
Last update
Aug 14, 2023

Study contacts

Benyan Luo, Prof
Contact
luobenyan@zju.edu.cn
0571-87236537
Benyan Luo, Prof, Dr
principal investigator · Zhejiang University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion